Liss, B. and Roeper, J. (2001) ATP-sensitive potassium channels in
dopaminergic neurons: transducers of mitochondrial dysfunction.
News Physiol. Sci. 16, 214–217
Seutin, V. et al. (1996) Sulfonylurea-sensitive potassium current
evoked by sodium-loading in rat midbrain dopamine neurons.
Neuroscience 71, 709–719
Liss, B. et al. (1999) The weaver mouse gain-of-function phenotype of
dopaminergic midbrain neurons is determined by coactivation of
wvGirk2 and K-ATP channels. J. Neurosci. 19, 8839–8848
Liss, B. et al. (2005) K-ATP channels promote the differential
degeneration of dopaminergic midbrain neurons. Nat. Neurosci. 8,
1742–1751
Sulzer, D. and Zecca, L. (2000) Intraneuronal dopamine–quinone
synthesis: a review. Neurotox. Res. 1, 181–195
Nakamura, K. et al. (2001) Tetrahydrobiopterin scavenges superoxide
in dopaminergic neurons. J. Biol. Chem. 276, 34402–34407
Staal, R.G. et al. (2004) Dopamine neurons release transmitter via a
flickering fusion pore. Nat. Neurosci. 7, 341–346
Sulzer, D. and Pothos, E.N. (2000) Presynaptic mechanisms that
regulate quantal size. Rev. Neurosci. 11, 159–212
Mosharov, E.V. et al. (2003) Intracellular patch electrochemistry:
regulation of cytosolic catecholamines in chromaffin cells. J.
Neurosci. 23, 5835–5845
Fahn, S. and Sulzer, d. (2004) Neurodegeneration and neuroprotection
in Parkinson's Disease. NeuroRx 1, 139–154
Compagni, A. and Christofori, G. (2000) Recent advances in research on
multistage tumorigenesis. Br. J. Cancer 83, 1–5
Sulzer, D. et al. (2000) Neuromelanin biosynthesis is driven by excess
cytosolic catecholamines not accumulated by synaptic vesicles. Proc.
Natl. Acad. Sci. U. S. A. 97, 11869–11874
Larsen, K.E. and Sulzer, D. (2002) Autophagy in neurons: a review.
Histol. Histopathol. 17, 897–908
Zecca, L. et al. (2003) Neuromelanin of the substantia nigra: a neuronal
black hole with protective and toxic characteristics. Trends Neurosci.
26, 578–580
Ulfig, N. (1989) Altered lipofuscin pigmentation in the basal nucleus
(Meynert) in Parkinson's disease. Neurosci. Res. 6, 456–462
Liang, C.L. et al. (2004) Inverse relationship between the contents of
neuromelanin pigment and the vesicular monoamine transporter-2:
human midbrain dopamine neurons. J. Comp. Neurol. 473, 97–106
McNaught, K.S. et al. (2004) Systemic exposure to proteasome
inhibitors causes a progressive model of Parkinson's disease. Ann.
Neurol. 56, 149–162
Beal, F. and Lang, A. (2006) The proteasomal inhibition model of
Parkinson's disease: ``boon or bust''? Ann. Neurol. 60, 158–161
Arrasate, M. et al. (2004) Inclusion body formation reduces levels of
mutant huntingtin and the risk of neuronal death. Nature 431, 805–810
Kitada, T. et al. (1998) Mutations in the parkin gene cause autosomal
recessive juvenile parkinsonism. Nature 392, 605–608
Von Coelln, R. et al. (2004) Loss of locus coeruleus neurons and reduced
startle in parkin null mice. Proc. Natl. Acad. Sci. U. S. A. 101,
10744–10749
Tan, J.M. and Dawson, T.M. (2006) Parkin blushed by PINK1. Neuron
50, 527–529
Shimura, H. et al. (2001) Ubiquitination of a new form of alphasynuclein by parkin from human brain: implications for Parkinson's
disease. Science 293, 263–269
Paxinou, E. et al. (2001) Induction of alpha-synuclein aggregation by
intracellular nitrative insult. J. Neurosci. 21, 8053–8061
Rideout, H.J. et al. (2001) Proteasomal inhibition leads to formation of
ubiquitin/a-synuclein-immunoreactive inclusions in PC12 cells. J.
Neurochem. 78, 899–908
LaVoie, M.J. et al. (2005) Dopamine covalently modifies and
functionally inactivates parkin. Nat. Med. 11, 1214–1221
Massey, A.C. et al. (2006) Consequences of the selective blockage of
chaperone-mediated autophagy. Proc. Natl. Acad. Sci. U. S. A. 103,
5805–5810
Norris, E.H. et al. (2005) Reversible inhibition of alpha-synuclein
fibrillization by dopaminochrome-mediated conformational alterations. J. Biol. Chem. 280, 21212–21219
Volles, M.J. et al. (2001) Vesicle permeabilization by protofibrillar
alpha-synuclein: implications for the pathogenesis and treatment of
Parkinson's disease. Biochemistry 40, 7812–7819
